Monday, January 13, 2025
HomeNews

News

Astellas and GO Therapeutics Enter into Strategic Research and License Agreement to Develop Novel Antibodies for Immuno-Oncology

Astellas Pharma Inc. (President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and GO Therapeutics, Inc. (Co-Founder and CEO: Constantine Theodoropulos, "GO") announced that Xyphos Biosciences,...

Amgen and NSG Biolabs Announce Golden Ticket to Boost Singapore’s Biotech Ecosystem

Amgen, a leading global biotechnology company, and NSG BioLabs, Singapore's largest and leading biotechnology (biotech) incubator, announced the launch of a 3-year Golden Ticket...

Yiannis Monovoukas and Monte Stettin, Noted Executives and Entrepreneurs, Appointed as Advisors and Observers to the Board of Directors of Athos Therapeutics

Athos Therapeutics, Inc. (the "Company"), a late-stage preclinical biotech company using artificial intelligence to develop small molecule therapeutics for immune-mediated diseases and cancer, announced...

Advanced Therapy Medicinal Products (ATMP) Service Providers Market worth $34.59 Billion by 2030 – Exclusive Report by InsightAce Analytic

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global ATMP Service Providers Market by Type of Services (Analytics/CRO...

Erbi Biosystems Strengthens Executive Leadership Team with Appointment of Chief Scientific Officer

Erbi Biosystems, Inc., a global leader in dose-scale, fully automated microbioreactors for cell therapy development and manufacturing, announced the appointment of Brad Hamilton to...
0FansLike
0FollowersFollow
spot_img

Hot Topics